Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's (LLY) branded weight-loss drug, Zepbound, on its telehealth platform.
The news is a big boost for Hims & H… [+2551 chars]
Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound - Investor's Business Daily
Hims & Hers will sell Eli Lilly's Zepbound on its telehealth platform.
By:ALLISON GATLIN, Investor's Business Daily
Source:Investor's Business Daily
Published:
Related News
UPS will slash 30,000 jobs amid ongoing split with Amazon - The Washington Post
The move comes after after the shipping giant eliminated 48,000 positions in 2025.
The Washington Post•Aaron Gregg
Two Defense Innovators Rally On $151 Billion Contract, With A Key Caveat - Investor's Business Daily
Karman, Redwire were awarded contracts as part of the antimissile defense SHIELD program, which has a total ceiling of $151 billion.
Investor's Business Daily
The market thinks BlackRock's Rick Rieder will be the next Fed chair. Here's what's at stake - CNBC
A five-month process of finding the next Fed chair appears to be down to its final days, with one candidate emerging as the betting favorite.
CNBC•Jeff Cox